Sprouts Farmers Market (SFM) 10-Q 8 Nov 22 2023 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Oct. 02, 2022	Nov. 04, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Oct. 02, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Trading Symbol	SFM
Entity Registrant Name	Sprouts Farmers Market, Inc.
Entity Central Index Key	0001575515
Entity Current Reporting Status	Yes
Current Fiscal Year End Date	--01-01
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		105,852,470
Entity Shell Company	false
Title of 12(b) Security	Common Stock, $0.001 par value
Security Exchange Name	NASDAQ
Entity Interactive Data Current	Yes
Entity File Number	001-36029
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	32-0331600
Entity Address, Address Line One	5455 East High Street
Entity Address, Address Line Two	Suite 111
Entity Address, City or Town	Phoenix
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85054
City Area Code	480
Local Phone Number	814-8016
Document Quarterly Report	true
Document Transition Report	false

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Oct. 02, 2022	Apr. 03, 2022	Jan. 02, 2022
Current assets:
Cash and cash equivalents	$ 316,042		$ 245,287
Accounts receivable, net	11,455		21,574
Inventories	301,667		265,387
Prepaid expenses and other current assets	43,867		35,468
Total current assets	673,031		567,716
Property and equipment, net of accumulated depreciation	694,098		716,029
Operating lease assets, net	1,081,514		1,072,019
Intangible assets, net of accumulated amortization	184,960		184,960
Goodwill	368,878		368,878
Other assets	15,036		13,513
Total assets	3,017,517		2,923,115
Current liabilities:
Accounts payable	166,968		145,901
Accrued liabilities	144,935		155,996
Accrued salaries and benefits	53,875		58,743
Current portion of operating lease liabilities	158,219		151,755
Current portion of finance lease liabilities	1,141		1,078
Total current liabilities	525,138		513,473
Long-term operating lease liabilities	1,095,154		1,095,909
Long-term debt and finance lease liabilities	258,992		259,656
Other long-term liabilities	38,486		36,306
Deferred income tax liability	58,919		57,895
Total liabilities	1,976,689		1,963,239
Commitments and contingencies (Note 6)
Stockholders’ equity:
Undesignated preferred stock; $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding	0		0
Common stock, $0.001 par value; 200,000,000 shares authorized, 106,491,322 shares issued and outstanding, October 2, 2022; 111,114,374 shares issued and outstanding, January 2, 2022	106		111
Additional paid-in capital	720,447		704,701
Accumulated other comprehensive income (loss)	498		(3,758)
Retained earnings	319,777		258,822
Total stockholders’ equity	1,040,828		959,876
Total liabilities and stockholders’ equity	$ 3,017,517		$ 2,923,115

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Oct. 02, 2022	Jan. 02, 2022
Statement of Financial Position [Abstract]
Undesignated preferred stock, par value	$ 0.001	$ 0.001
Undesignated preferred stock, shares authorized	10,000,000	10,000,000
Undesignated preferred stock, shares issued	0	0
Undesignated preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	106,491,322	111,114,374
Common stock, shares outstanding	106,491,322	111,114,374

Consolidated Statements of Inco

Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2022	Oct. 03, 2021	Oct. 02, 2022	Oct. 03, 2021
Income Statement [Abstract]
Net sales	$ 1,591,026	$ 1,509,633	$ 4,827,669	$ 4,607,073
Cost of sales	1,007,376	969,904	3,051,914	2,931,089
Gross profit	583,650	539,729	1,775,755	1,675,984
Selling, general and administrative expenses	460,834	423,416	1,382,854	1,299,498
Depreciation and amortization (exclusive of depreciation included in cost of sales)	30,313	30,377	93,377	92,036
Store closure and other costs, net	2,164	128	3,034	1,757
Income from operations	90,339	85,808	296,490	282,693
Interest expense, net	1,951	2,911	7,648	8,840
Income before income taxes	88,388	82,897	288,842	273,853
Income tax provision	22,648	19,030	72,798	65,924
Net income	$ 65,740	$ 63,867	$ 216,044	$ 207,929
Net income per share:
Basic	$ 0.61	$ 0.56	$ 1.98	$ 1.78
Diluted	$ 0.61	$ 0.56	$ 1.97	$ 1.77
Weighted average shares outstanding:
Basic	107,229	114,201	109,066	116,497
Diluted	108,095	114,818	109,888	117,252

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2022	Oct. 03, 2021	Oct. 02, 2022	Oct. 03, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 65,740	$ 63,867	$ 216,044	$ 207,929
Other comprehensive income (loss), net of tax
Unrealized gains (losses) on cash flow hedging activities, net of income tax of $149, $707, $2,167 and $2,192	432	2,044	6,266	6,339
Reclassification of net gains (losses) on cash flow hedges to net income, net of income tax of ($274), ($370), ($651) and ($740)	(127)	(1,076)	(2,010)	(3,216)
Total other comprehensive income (loss)	305	968	4,256	3,123
Comprehensive income	$ 66,045	$ 64,835	$ 220,300	$ 211,052

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income (Unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2022	Oct. 03, 2021	Oct. 02, 2022	Oct. 03, 2021
Statement of Comprehensive Income [Abstract]
Income tax expenses (Benefit) on cash flow hedging activities	$ 149	$ 707	$ 2,167	$ 2,192
Income tax expenses (Benefit) for reclassification of net gains (losses) on cash flow hedges	$ (44)	$ (372)	$ (695)	$ (1,112)

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid In Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]
Beginning Balance at Jan. 03, 2021	$ 881,293	$ 118	$ 686,648	$ 203,001	$ (8,474)
Beginning Balance, Shares at Jan. 03, 2021		117,953,435
Net income	207,929			207,929
Other comprehensive income (loss)	3,123				3,123
Issuance of shares under stock plans	1,918		1,918
Issuance of shares under stock plans, Shares		562,021
Repurchase and retirement of common stock	(137,484)	$ 5		(137,479)
Repurchase and retirement of common stock, Shares		(5,360,037)
Share-based compensation	11,304		11,304
Ending Balance at Oct. 03, 2021	968,083	$ 113	699,870	273,451	(5,351)
Ending Balance, Shares at Oct. 03, 2021		113,155,419
Beginning Balance at Jul. 04, 2021	949,123	$ 115	695,745	259,582	(6,319)
Beginning Balance, Shares at Jul. 04, 2021		115,180,832
Net income	63,867			63,867
Other comprehensive income (loss)	968				968
Issuance of shares under stock plans	672		672
Issuance of shares under stock plans, Shares		54,007
Repurchase and retirement of common stock	(50,000)	$ (2)		(49,998)
Repurchase and retirement of common stock, Shares		(2,079,420)
Share-based compensation	3,453		3,453
Ending Balance at Oct. 03, 2021	968,083	$ 113	699,870	273,451	(5,351)
Ending Balance, Shares at Oct. 03, 2021		113,155,419
Beginning Balance at Jan. 02, 2022	959,876	$ 111	704,701	258,822	(3,758)
Beginning Balance, Shares at Jan. 02, 2022		111,114,374
Net income	216,044			216,044
Other comprehensive income (loss)	4,256				4,256
Issuance of shares under stock plans	4,074		4,074
Issuance of shares under stock plans, Shares		814,002
Repurchase and retirement of common stock	(155,094)	$ (5)		(155,089)
Repurchase and retirement of common stock, Shares		(5,437,054)
Share-based compensation	11,672		11,672
Ending Balance at Oct. 02, 2022	1,040,828	$ 106	720,447	319,777	498
Ending Balance, Shares at Oct. 02, 2022		106,491,322
Beginning Balance at Jul. 03, 2022	1,013,690	$ 108	715,331	298,058	(193)
Beginning Balance, Shares at Jul. 03, 2022		107,967,677
Net income	65,740			65,740
Other comprehensive income (loss)	305				305
Issuance of shares under stock plans	1,364		1,364
Issuance of shares under stock plans, Shares		81,841
Repurchase and retirement of common stock	(44,023)	$ (2)	(44,021)
Repurchase and retirement of common stock, Shares		(1,558,196)
Share-based compensation	3,752		3,752
Ending Balance at Oct. 02, 2022	$ 1,040,828	$ 106	$ 720,447	$ 319,777	$ 498
Ending Balance, Shares at Oct. 02, 2022		106,491,322

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Oct. 02, 2022	Oct. 03, 2021
Operating activities
Net income	$ 216,044	$ 207,929
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	96,057	94,422
Operating lease asset amortization	87,316	80,295
Store closure and other costs, net	171	0
Share-based compensation	11,672	11,304
Deferred income taxes	1,025	2,085
Other non-cash items	404	883
Changes in operating assets and liabilities:
Accounts receivable	16,491	12,999
Inventories	(36,280)	(16,860)
Prepaid expenses and other current assets	(7,880)	(6,001)
Other assets	1,678	(2,834)
Accounts payable	23,121	29,479
Accrued liabilities	2,482	1,046
Accrued salaries and benefits	(4,868)	(30,544)
Operating lease liabilities	(99,055)	(88,664)
Other long-term liabilities	(1,588)	1,120
Cash flows from operating activities	306,790	296,659
Investing activities
Purchases of property and equipment	(80,749)	(70,010)
Cash flows used in investing activities	(80,749)	(70,010)
Financing activities
Payments on finance lease liabilities	(600)	(507)
Payments of deferred financing costs	(3,373)	0
Repurchase of common stock	(155,094)	(137,484)
Proceeds from exercise of stock options	4,074	1,918
Cash flows used in financing activities	(154,993)	(136,073)
Increase in cash, cash equivalents, and restricted cash	71,048	90,576
Cash, cash equivalents, and restricted cash at beginning of the period	247,004	171,441
Cash, cash equivalents, and restricted cash at the end of the period	318,052	262,017
Supplemental disclosure of cash flow information
Cash paid for interest	8,415	8,710
Cash paid for income taxes	65,671	65,783
Leased assets obtained in exchange for new operating lease liabilities	96,956	96,713
Supplemental disclosure of non-cash investing and financing activities
Property and equipment in accounts payable and accrued liabilities	$ 17,834	$ 19,228

Basis of Presentation

Basis of Presentation	9 Months Ended
	Oct. 02, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	1. Basis of Presentation Sprouts Farmers Market, Inc., a Delaware corporation, through its subsidiaries, operates as a healthy grocery store that offers a unique grocery experience featuring an open layout with fresh produce at the heart of the store. The Company continues to bring the latest in wholesome, innovative products made with lifestyle-friendly ingredients such as organic, plant-based and gluten-free. As of October 2, 2022 , the Company operated 379 stores in 23 states. The “Company” is used to refer collectively to Sprouts Farmers Market, Inc. and unless the context otherwise requires, its subsidiaries. The accompanying unaudited consolidated financial statements include the accounts of the Company in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial statements and are in the form prescribed by the Securities and Exchange Commission in instructions to Form 10-Q and Rule 10-01 of Regulation S-X. In the opinion of management, the accompanying consolidated financial statements reflect all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company's financial position, results of operations and cash flows for the periods indicated. All material intercompany accounts and transactions have been eliminated in consolidation. Interim results are not necessarily indicative of results for any other interim period or for a full fiscal year. The information included in these consolidated financial statements and notes thereto should be read in conjunction with Management’s Discussion and Analysis of Financial Condition and Results of Operations included herein and Management’s Discussion and Analysis of Financial Condition and Results of Operations and the consolidated financial statements and notes thereto for the fiscal year ended January 2, 2022 (“fiscal year 2021”) included in the Company’s Annual Report on Form 10-K, filed on February 24, 2022. The year-end balance sheet data was derived from audited financial statements but does not include all disclosures required by GAAP. The Company reports its results of operations on a 52- or 53-week fiscal calendar ending on the Sunday closest to December 31. The fiscal year ending January 1, 2023 (“fiscal year 2022”) and fiscal year 2021 are 52-week years. The Company reports its results of operations on a 13-week quarter, except for 53-week fiscal years (in which the fourth quarter has 14 weeks). All dollar amounts are in thousands, unless otherwise noted.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Oct. 02, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Revenue Recognition The Company’s performance obligations are satisfied upon the transfer of goods to the customer, which occurs at the point of sale, and payment from customers is also due at the time of sale. Proceeds from the sale of gift cards are recorded as a liability at the time of sale and recognized as sales when they are redeemed by the customer and the performance obligation is satisfied by the Company. The Company’s gift cards do not expire. Based on historical redemption rates, a small and relatively stable percentage of gift cards will never be redeemed, referred to as "breakage." Estimated breakage revenue is recognized over time in proportion to actual gift card redemptions and was not material in any period presented. Balance at Gift Cards Issued During (1) Revenue Recognized from Balance at Gift card liability, net $ 12,586 $ 1,911 $ ( 5,350 ) $ 9,147 (1) net of estimated breakage The Company does not have any material contract assets or receivables from contracts with customers, any revenue recognized in the current period from performance obligations satisfied in previous periods, or any remaining performance obligations as of October 2, 2022 . Restricted Cash Restricted cash relates to defined benefit plan forfeitures as well as healthcare, general liability and workers’ compensation restricted funds of approximately $ 2.0 million and $ 1.7 million as of October 2, 2022 and January 2, 2022 , respectively. These balances are included in prepaid expenses and other current assets in the consolidated balance sheets. Recently Adopted Accounting Pronouncements Reference Rate Reform In March 2020 and January 2021, the FASB issued ASU no. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” and ASU 2021-01, “Reference Rate Reform (Topic 848): Scope,” respectively. The amendments in these updates provide optional expedients and exceptions for a limited period of time to ease the potential burden in accounting for contracts, hedging relationships, and other transactions affected by reference rate reform. In the thirty-nine weeks ended October 2, 2022 , the Company adopted certain optional expedients provided under Topic 848 that permit its hedging relationships to continue without de-designation upon changes due to reference rate reform. The adoption of this guidance resulted in no material impact to the Company’s consolidated financial statements. See Note 10, “Derivative Financial Instruments” for more information on our hedging activities. The optional expedients and accounting relief in Topic 848 remain effective through December 31, 2022. Recently Issued Accounting Pronouncements Not Yet Adopted No other new accounting pronouncements issued or effective during the thirteen weeks ended October 2, 2022 had, or are expected to have, a material impact on the Company’s consolidated financial statements.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Oct. 02, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	3. Fair Value Measurements The Company records its financial assets and liabilities in accordance with the framework for measuring fair value in accordance with GAAP. This framework establishes a fair value hierarchy that prioritizes the inputs used to measure fair value: Level 1: Quoted prices for identical instruments in active markets. Level 2: Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets. Level 3: Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. Fair value measurements of nonfinancial assets and nonfinancial liabilities are primarily used in the valuation of derivative instruments, impairment analysis of goodwill, intangible assets and long-lived assets. The following tables present the fair value hierarchy for the Company’s financial liabilities measured at fair value on a recurring basis as of October 2, 2022 and January 2, 2022: October 2, 2022 Level 1 Level 2 Level 3 Total Long-term debt $ — $ 250,000 $ — $ 250,000 Total financial liabilities $ — $ 250,000 $ — $ 250,000 Interest rate swap asset $ — $ 687 $ — $ 687 Total assets $ — $ 687 $ — $ 687 January 2, 2022 Level 1 Level 2 Level 3 Total Long-term debt $ — $ 250,000 $ — $ 250,000 Interest rate swap liability — 5,107 — 5,107 Total financial liabilities $ — $ 255,107 $ — $ 255,107 The Company’s interest rate swaps are considered Level 2 in the hierarchy and are valued using an income approach. Expected future cash flows are converted to a present value amount based on market expectations of the yield curve on floating interest rates, which is readily available on public markets. The determination of fair values of certain tangible and intangible assets for purposes of the Company’s goodwill impairment evaluation as described above is based upon Level 3 inputs. The weighted average cost of capital is estimated using information from comparable companies and management’s judgment related to the risk associated with the operations of the stores. Cash, cash equivalents, restricted cash, accounts receivable, prepaid expenses and other current assets, accounts payable, accrued liabilities, and accrued salaries and benefits approximate fair value because of the short maturity of those instruments. Based on comparable open market transactions, the fair value of the long-term debt approximated carrying value as of October 2, 2022 and January 2, 2022 .

Long-Term Debt and Finance Leas

Long-Term Debt and Finance Lease Liabilities	9 Months Ended
	Oct. 02, 2022
Long Term Debt And Finance Lease Liabilities [Abstract]
Long-Term Debt and Finance Lease Liabilities	4. Long-Term Debt and Finance Lease Liabilities A summary of long-term debt and finance lease liabilities is as follows: As of Facility Maturity Interest Rate October 2, 2022 January 2, 2022 Senior secured debt $ 700.0 million Credit Agreement March 25, 2027 Variable $ 250,000 $ — Former Credit Facility March 27, 2023 Variable — 250,000 Finance lease liabilities Various n/a 8,992 9,656 Long-term debt and finance lease liabilities $ 258,992 $ 259,656 New Credit Agreement The Company’s subsidiary, Sprouts Farmers Markets Holdings, LLC (“Intermediate Holdings”), is the borrower under a credit agreement entered into on March 25, 2022 (the “Credit Agreement”). The Credit Agreement provides for a revolving credit facility (the "Revolving Credit Facility") with an initial aggregate commitment of $ 700.0 million. Amounts outstanding under the Credit Agreement may be increased from time to time in accordance with an expansion feature set forth in the Credit Agreement. The Company capitalized debt issuance costs of $ 3.4 million related to the Credit Agreement, which, combined with the remaining $ 0.5 million debt issuance costs in respect of that certain amended and restated credit agreement entered into on March 27, 2018, by and among the Company, Intermediate Holdings, certain lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent (the “Former Credit Facility”), which remained outstanding as of the time of Intermediate Holdings’ entry into the Credit Agreement, are being amortized on a straight-line basis to interest expense over the five-year term of the Credit Agreement. The Credit Agreement provides for a $ 70.0 million letter of credit sub-facility (the "Letter of Credit Sub-Facility") and a $ 50.0 million swingline facility. Letters of credit issued under the Credit Agreement reduce the capacity of Intermediate Holdings to borrow under the Revolving Credit Facility. Letters of credit totaling $ 24.8 million have been issued as of October 2, 2022 under the Letter of Credit Sub-Facility, primarily to support the Company’s insurance programs. Guarantees Obligations under the Credit Agreement are guaranteed by the Company and substantially all of its existing and future wholly-owned material domestic subsidiaries, and are secured by first-priority security interests in substantially all of the assets of the Company, Intermediate Holdings, and the subsidiary guarantors, including, without limitation, a pledge by the Company of its equity interest in Intermediate Holdings. Interest and Fees Loans under the Credit Agreement will initially bear interest, at the Company's option, either at the Term SOFR (with a floor of 0.00%) plus a 0.10 % SOFR adjustment and 1.00 % per annum or base rate (with a floor of 0.00%) plus 0.00 % per annum. The interest rate margins are subject to upward adjustments pursuant to a pricing grid based on the Company’s total net leverage ratio as set forth in the Credit Agreement and to upward or downward adjustments of up to 0.05 % based upon the achievement of certain diversity and sustainability-linked metric thresholds, as set forth in the Credit Agreement. Under the terms of the Credit Agreement, the Company is obligated to pay a commitment fee on the available unused amount of the commitments, which commitment fee ranges between 0.10 % to 0.225 % per annum, pursuant to a pricing grid based on the Company’s total net leverage ratio. The commitment fees are subject to upward or downward adjustments of up to 0.01 % based upon the achievement of certain diversity and sustainability-linked metric thresholds, as set forth in the Credit Agreement. As of October 2, 2022, loans outstanding under the Credit Agreement bore interest at Term SOFR (as defined in the Credit Agreement) plus a 0.10 % SOFR adjustment and 1.00 % per annum. The effective interest rate on 100 % of outstanding debt under the Credit Agreement is fixed, reflecting the effects of floating to fixed interest rate swaps (see Note 10, “Derivative Financial Instruments”). As of October 2, 2022, outstanding letters of credit issued under the Credit Agreement were subject to a participation fee of 1.00 % per annum and an issuance fee of 0.125 % per annum. Payments and Borrowings The Credit Agreement is scheduled to mature, and the commitments thereunder will terminate on March 25, 2027 , subject to extensions as set forth therein. The Company may prepay loans and permanently reduce commitments under the Credit Agreement at any time in agreed-upon minimum principal amounts, without premium or penalty (except SOFR breakage costs, if applicable). In connection with the execution of the Credit Agreement, the obligations as borrower under the Former Credit Facility were prepaid and terminated. During the thirteen and thirty-nine weeks ended October 2, 2022 , the Company made no additional borrowings or principal payments, resulting in total outstanding debt under the Credit Agreement of $ 250.0 million as of October 2, 2022. Covenants The Credit Agreement contains financial, affirmative and negative covenants. The negative covenants include, among other things, limitations on the Company’s ability to: • incur additional indebtedness; • grant additional liens; • enter into sale-leaseback transactions; • make loans or investments; • merge, consolidate or enter into acquisitions; • pay dividends or distributions; • enter into transactions with affiliates; • enter into new lines of business; • modify the terms of certain debt or other material agreements; and • change its fiscal year. Each of these covenants is subject to customary and other agreed-upon exceptions. In addition, the Credit Agreement requires that the Company and its subsidiaries maintain a maximum total net leverage ratio not to exceed 3.75 to 1.00, which ratio may be increased from time to time in connection with certain permitted acquisitions pursuant to conditions as set forth in the Credit Agreement, and a minimum interest coverage ratio not to be less than 3.00 to 1.00. Each of these covenants is tested as of the last day of each fiscal quarter. The Company was in compliance with all applicable covenants under the Credit Agreement as of October 2, 2022 .

Income Taxes

Income Taxes	9 Months Ended
	Oct. 02, 2022
Income Tax Disclosure [Abstract]
Income Taxes	5. Income Taxes The Company’s effective tax rate increased to 25.6 % for the thirteen weeks ended October 2, 2022 , compared to 23.0 % for the thirteen weeks ended October 3, 2021.The increase in the effective tax rate is primarily due to a decrease in enhanced charitable contributions due to the expiration of CARES Act benefits as well as an increase of non-deductible executive compensation. The Company’s effective tax rate increased to 25.2 % for the thirty-nine weeks ended October 2, 2022 , compared to 24.1 % for the thirty-nine weeks ended October 3, 2021 .The increase in the effective tax rate is primarily due to a decrease in enhanced charitable contributions due to the expiration of CARES Act benefits as well as an increase of non-deductible executive compensation, partially offset by an increase in benefit from share-based payment awards in the current year. The income tax effect resulting from excess tax benefits of share-based payment awards were $ 1.6 million and $ 0.2 million for the thirty-nine weeks ended October 2, 2022 and October 3, 2021, respectively. The Company files income tax returns for federal purposes and in many states. The Company’s tax filings remain subject to examination by applicable tax authorities for a certain length of time, generally three years, following the tax year to which those filings relate.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Oct. 02, 2022
Related Party Transactions [Abstract]
Related Party Transactions	6. Related Party Transactions On May 24, 2022, the Company appointed a new member to its board of directors who is an executive officer of a company that is a supplier of nutrition bars and related products to the Company for resale. The cost of sales recognized from this supplier was $ 1.2 million during the thirteen weeks ended October 2, 2022 and was $ 2.5 million since the beginning of the second quarter of 2022.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Oct. 02, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	. Commitments and Contingencies The Company is exposed to claims and litigation matters arising in the ordinary course of business and uses various methods to resolve these matters that are believed to best serve the interests of the Company’s stakeholders. The Company’s primary contingencies are associated with self-insurance obligations and litigation matters. Self-insurance liabilities require significant judgment and actual claim settlements and associated expenses may differ from the Company’s current provisions for loss. Proposition 65 Coffee Action On April 13, 2010, an organization named Council for Education and Research on Toxics (“CERT”) filed a lawsuit in the Superior Court of the State of California, County of Los Angeles, against nearly 80 defendants who manufacture, package, distribute or sell brewed coffee, including the Company. CERT alleged that the defendants failed to provide warnings for their coffee products of exposure to the chemical acrylamide as required under California Health and Safety Code section 25249.5, the California Safe Drinking Water and Toxic Enforcement Act of 1986, better known as Proposition 65. CER T seeks equitable relief, i ncluding providing warnings to consumers of coffee products, as well as civil penalties. The Company, as part of a joint defense group, asserted multiple defenses against the lawsuit. On May 7, 2018, the trial court issued a ruling adverse to defendants on these defenses to liability. On October 1, 2019, before the court tried damages, remedies and attorneys' fees, California’s Office of Environmental Health Hazard Assessment adopted a regulation that exempted “Exposures to listed chemicals in coffee created by and inherent in the processes of roasting coffee beans or brewing coffee” from Proposition 65’s warning requirement. On August 25, 2020, the court granted the defense motion for summary judgment based on the regulation, and the case was dismissed. On November 20, 2020, CERT filed a notice of appeal to appeal the ruling on the defense motion for summary judgment. On October 26, 2022, the appellate court affirmed the trial court’s decision. As the Company expects CERT to appeal this ruling, the Company is unable to predict or reasonably estimate any potential loss or effect on the Company or its operations. Accordingly, no loss contingency was recorded for this matter.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Oct. 02, 2022
Equity [Abstract]
Stockholders' Equity	. Stockholders’ Equity Share Repurchases On March 2, 2022, the Company's board of directors authorized a new $ 600 million share repurchase program for its common stock. The new authorization replaced the Company's then-existing share repurchase authorization of $ 300 million that was due to expire on March 3, 2024, of which $ 99.8 million remained available upon its replacement. No further shares may be repurchased under the $ 300 million authorization. The following table outlines the common stock share repurchase programs authorized by the Company’s board of directors and the related repurchase activity and available authorization as of October 2, 2022. Effective date Expiration date Amount Cost of Authorization March 3, 2021 March 2, 2022 $ 300,000 $ 200,200 $ — March 2, 2022 December 31, 2024 $ 600,000 $ 143,236 $ 456,764 The shares under the Company’s repurchase programs may be purchased on a discretionary basis from time to time through the applicable expiration date, subject to general business and market conditions and other investment opportunities, through open market purchases, privately negotiated transactions, or other means, including through Rule 10b5-1 trading plans. The board’s authorization of the share repurchase programs does not obligate the Company to acquire any particular amount of common stock, and the repurchase programs may be commenced, suspended, or discontinued at any time. Share repurchase activity under the Company’s repurchase programs for the periods indicated was as follows (total cost in thousands): Thirteen weeks ended Thirty-nine weeks ended October 2, 2022 October 3, 2021 October 2, 2022 October 3, 2021 Number of common shares acquired 1,558,196 2,079,420 5,437,054 5,360,037 Average price per common share acquired $ 28.25 $ 24.05 $ 28.53 $ 25.65 Total cost of common shares acquired $ 44,023 $ 50,000 $ 155,094 $ 137,484 Shares purchased under the Company’s repurchase programs were subsequently retired and the excess of the repurchase price over par value was charged to retained earnings. Subsequent to October 2, 2022 and through November 4, 2022 , the Company repurchased an additional 0.6 million shares of common stock for $ 17.8 million.

Net Income Per Share

Net Income Per Share	9 Months Ended
	Oct. 02, 2022
Earnings Per Share [Abstract]
Net Income Per Share	9. Net Income Per Share The computation of basic net income per share is based on the number of weighted average shares outstanding during the period. The computation of diluted net income per share includes the dilutive effect of share equivalents consisting of incremental shares deemed outstanding from the assumed exercise of options, assumed vesting of restricted stock units (“RSUs”) and assumed vesting of performance share awards (“PSAs”). PSAs are included in the computation of diluted net income per share only to the extent that the underlying performance conditions are satisfied prior to the end of the reporting period or would be satisfied if the end of the reporting period were the end of the related performance period, and if the effect would be dilutive. A reconciliation of the numerators and denominators of the basic and diluted net income per share calculations is as follows (in thousands, except per share amounts): Thirteen weeks ended Thirty-nine weeks ended October 2, 2022 October 3, 2021 October 2, 2022 October 3, 2021 Basic net income per share: Net income $ 65,740 $ 63,867 $ 216,044 $ 207,929 Weighted average shares outstanding 107,229 114,201 109,066 116,497 Basic net income per share $ 0.61 $ 0.56 $ 1.98 $ 1.78 Diluted net income per share: Net income $ 65,740 $ 63,867 $ 216,044 $ 207,929 Weighted average shares outstanding - 107,229 114,201 109,066 116,497 Dilutive effect of share-based awards: Assumed exercise of options to purchase 314 197 318 211 RSUs 266 245 371 376 PSAs 286 175 133 168 Weighted average shares and 108,095 114,818 109,888 117,252 Diluted net income per share $ 0.61 $ 0.56 $ 1.97 $ 1.77 For the thirteen weeks ended October 2, 2022 , the Company had 0.3 million options and 0.3 million PSAs outstanding which were excluded from the computation of diluted net income per share as those awards would have been antidilutive or were performance awards with performance conditions not yet deemed met. For the thirteen weeks ended October 3, 2021 , the Company had 0.5 million options and 0.3 million PSAs outstanding which were excluded from the computation of diluted net income per share as those awards would have been antidilutive or were performance awards with performance conditions not yet deemed met. For the thirty-nine weeks ended October 2, 2022 , the Company had 0.5 million options, 0.1 million RSUs, and 0.3 million PSAs outstanding which were excluded from the computation of diluted net income per share as those awards would have been antidilutive or were performance awards with performance conditions not yet deemed met. For the thirty-nine weeks ended October 3, 2021 , the Company had 0.5 million options and 0.3 million PSAs outstanding which were excluded from the computation of diluted net income per share as those awards would have been antidilutive or were performance awards with performance conditions not yet deemed met.

Derivative Financial Instrument

Derivative Financial Instruments	9 Months Ended
	Oct. 02, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	. Derivative Financial Instruments The Company entered into an interest rate swap agreement in December 2017 to manage its cash flow associated with variable interest rates. This forward contract has been designated and qualifies as a cash flow hedge, and its change in fair value is recorded as a component of other comprehensive income and reclassified into earnings in the same period or periods in which the forecasted transaction occurs. The forward contract initially consisted of five cash flow hedges, of which one was outstanding at October 2, 2022. To qualify as a hedge, the Company needs to formally document, designate and assess the effectiveness of the transactions that receive hedge accounting. The notional dollar amount of the one outstanding swap was $ 250.0 million at October 2, 2022 and January 2, 2022 , under which the Company pays a fixed rate and receives a variable rate of interest (cash flow swap). The cash flow swap hedges the change in interest rates on debt related to fluctuations in interest rates and has a length of one year , maturing in 2022 . This interest rate swap has been designated and qualifies as a cash flow hedge and has met the requirements to assume zero ineffectiveness. The Company reviews the effectiveness of its hedging instruments on a quarterly basis. During the first quarter of 2022, the Company elected to apply certain hedge accounting optional expedients allowed under Topic 848. The expedients allow the Company to continue the method of assessing effectiveness as documented in the original hedge documentation and allows the reference rate on the hypothetical derivative to match the reference rate on the hedging instrument . The counterparties to these derivative financial instruments are major financial institutions. The Company evaluates the credit ratings of the financial institutions and believes that credit risk is at an acceptable level. The following table summarizes the fair value of the Company’s derivative instruments designated as hedging instruments: As of As of Balance Sheet Location Fair Value Balance Sheet Location Fair Value Interest rate swaps Other current assets $ 687 Other current assets $ — Interest rate swaps Accrued liabilities $ — Accrued liabilities $ 5,107 The gain or loss on these derivative instruments is recognized in other comprehensive income, net of tax, with the portion related to current period interest payments reclassified to interest expense, net on the consolidated statements of income. The following table summarizes these losses classified on the consolidated statements of income: Thirteen weeks ended Thirty-nine weeks ended October 2, 2022 October 3, 2021 October 2, 2022 October 3, 2021 Consolidated Statements of Interest expense, net $ 171 $ 1,448 $ 2,705 $ 4,328

Comprehensive Income

Comprehensive Income	9 Months Ended
	Oct. 02, 2022
Equity [Abstract]
Comprehensive Income	11. Comprehensive Income The following table presents the changes in accumulated other comprehensive income (loss) for the thirty-nine weeks ended October 3, 2021 and October 2, 2022. Cash Flow Balance at January 3, 2021 $ ( 8,474 ) Other comprehensive income (loss), net of tax Unrealized gains on cash flow hedging activities, net of income tax of $ 2,192 6,339 Reclassification of net losses on cash flow hedges to net income, net of income 1,112 ) ( 3,216 ) Total other comprehensive income (loss) 3,123 Balance at October 3, 2021 $ ( 5,351 ) Balance at January 2, 2022 $ ( 3,758 ) Other comprehensive income (loss), net of tax Unrealized gains on cash flow hedging activities, net of income tax of $ 2,167 6,266 Reclassification of net losses on cash flow hedges to net income, net of income 695 ) ( 2,010 ) Total other comprehensive income (loss) 4,256 Balance at October 2, 2022 $ 498 Amounts reclassified from accumulated other comprehensive income (loss) are included within interest expense, net on the consolidated statements of income.

Segments

Segments	9 Months Ended
	Oct. 02, 2022
Segment Reporting [Abstract]
Segments	12. Segments The Company has one reportable and one operating segment, healthy grocery stores. In accordance with ASC 606, the following table represents a disaggregation of revenue for the thirteen and thirty-nine weeks ended October 2, 2022 and October 3, 2021. Thirteen weeks ended October 2, 2022 October 3, 2021 Perishables $ 928,908 58.4 % $ 867,880 57.5 % Non-Perishables 662,118 41.6 % 641,753 42.5 % Net Sales $ 1,591,026 100.0 % $ 1,509,633 100.0 % Thirty-nine weeks ended October 2, 2022 October 3, 2021 Perishables $ 2,817,268 58.4 % $ 2,668,532 57.9 % Non-Perishables 2,010,401 41.6 % 1,938,541 42.1 % Net Sales $ 4,827,669 100.0 % $ 4,607,073 100.0 % The Company categorizes the varieties of products it sells as perishable and non-perishable. Perishable product categories include produce, meat and meat alternatives, seafood, deli, bakery, floral and dairy and dairy alternatives. Non-perishable product categories include grocery, vitamins and supplements, bulk items, frozen foods, beer and wine, and natural health and body care.

Share-Based Compensation

Share-Based Compensation	9 Months Ended
	Oct. 02, 2022
Share-Based Payment Arrangement [Abstract]
Share-Based Compensation	13. Share-Based Compensation 2022 Incentive Plan In March 2022, the Company’s board of directors adopted the Sprouts Farmers Market, Inc. 2022 Omnibus Incentive Compensation Plan (the “2022 Incentive Plan”), which became effective May 25, 2022, upon approval by the Company’s stockholders. The 2022 Incentive Plan provides team members of the Company, certain consultants and advisors who perform services for the Company, and non-employee members of the Company's board of directors with the opportunity to receive grants of equity awards, including stock options, RSUs, PSAs, and other stock-based awards. The 2022 Incentive Plan replaced the 2013 Incentive Plan (as described below). Awards Granted under the 2022 Incentive Plan During the thirty-nine weeks ended October 2, 2022, the Company granted the following share-based compensation awards under the 2022 Incentive Plan: Grant Date RSUs PSAs Options June 7, 2022 58,057 — — September 7, 2022 21,598 — — Total 79,655 — — Weighted-average grant date fair value $ 27.75 $ — $ — Weighted-average exercise price — — — The aggregate number of shares of common stock that may be issued to team members and directors under the 2022 Incentive Plan may not exceed 6,600,000 , subject to the following adjustments. If any awards granted under the 2022 Incentive Plan, terminate, expire, or are cancelled, forfeited, exchanged, or surrendered without having been exercised, vested or paid in shares, the shares will again be available for purposes of the 2022 Incentive Plan. In addition, the number of shares subject to outstanding awards under the Sprouts Farmers Market, Inc. 2013 Incentive Plan (the “2013 Incentive Plan”) that terminate, expire, are paid in cash, or are cancelled, forfeited, exchanged, or surrendered without having been exercised, vested, or paid in shares under the 2013 Incentive Plan after the effective date of the 2022 Incentive Plan will be available for issuance under the 2022 Incentive Plan. As of October 2, 2022 , there were 79,655 stock awards outstanding and 6,621,800 shares remaining available for issuance under the 2022 Incentive Plan. 2013 Incentive Plan Prior to the adoption of the 2022 Incentive Plan, the 2013 Incentive Plan served as the umbrella plan for the Company’s share-based and cash-based incentive compensation programs for its directors, officers and other team members. Upon adoption of the 2022 Incentive Plan on May 25, 2022, no further awards will be granted under the 2013 Incentive Plan, but awards outstanding under the 2013 Incentive Plan will remain outstanding in accordance with their terms and the terms of the 2013 Incentive Plan. Awards Granted under the 2013 Incentive Plan During the thirty-nine weeks ended October 2, 2022, the Company granted the following share-based compensation awards under the 2013 Incentive Plan: Grant Date RSUs PSAs Options March 15, 2022 370,177 147,846 211,352 March 21, 2022 104,913 14,260 20,270 Total 475,090 162,106 231,622 Weighted-average grant date fair value $ 31.60 $ 31.52 $ 10.58 Weighted-average exercise price — — $ 31.52 Stock Options The Company uses the Black-Scholes option pricing model to estimate the fair value of options at grant date. Options vest in accordance with the terms set forth in the grant letter. Time-based options vest annually over a period of three years . RSUs The fair value of RSUs is based on the closing price of the Company’s common stock on the grant date. RSUs generally vest annually over a period of two or three years from the grant date. PSAs PSAs granted in 2018 were subject to the Company achieving certain earnings before interest and taxes (“EBIT”) performance targets for the 2020 fiscal year. The criteria was based on a range of performance targets in which grantees may earn 0 % to 200 % of the base number of awards granted. The performance conditions with respect to fiscal year 2020 EBIT were deemed to have been met, and the PSAs vested at the maximum pay out level on the third anniversary of the grant date (March 2021). There were no outstanding 2018 PSAs as of October 2, 2022. PSAs granted in 2019 are subject to the Company achieving certain EBIT performance targets for the 2021 fiscal year. The criteria is based on a range of performance targets in which grantees may earn 0 % to 200 % of the base number of awards granted. The performance conditions with respect to fiscal year 2021 EBIT were deemed to have been met, and the PSAs vested at the maximum pay out level on the third anniversary of the grant date (March 2022). During the thirty-nine weeks ended October 2, 2022 , 208,172 of the 2019 PSAs vested. There were no outstanding 2019 PSAs as of October 2, 2022. PSAs granted in 2020 are subject to the Company achieving certain earnings before taxes (“EBT”) performance targets for the 2022 fiscal year. The criteria is based on a range of performance targets in which grantees may earn 0 % to 200 % of the base number of awards granted. If performance conditions are met, the applicable number of performance shares will vest on the third anniversary of the grant date (March 2023). PSAs granted in 2021 are subject to the Company achieving certain EBIT performance targets for the 2023 fiscal year. The criteria is based on a range of performance targets in which grantees may earn 0 % to 200 % of the base number of awards granted. If performance conditions are met, the applicable number of performance shares will vest on the third anniversary of the grant date (March 2024). PSAs granted in 2022 are subject to the Company achieving certain EBIT performance targets for the 2024 fiscal year. The criteria is based on a range of performance targets in which grantees may earn 0 % to 200 % of the base number of awards granted. If performance conditions are met, the applicable number of performance shares will vest on the third anniversary of the grant date (March 2025). Share-based Compensation Expense The Company presents share-based compensation expense in selling, general and administrative expenses on the Company’s consolidated statements of income. The amount recognized was as follows: Thirteen weeks ended Thirty-nine weeks ended October 2, 2022 October 3, 2021 October 2, 2022 October 3, 2021 Share-based compensation expense $ 3,752 $ 3,453 $ 11,672 $ 11,304 The following share-based awards were outstanding as of October 2, 2022 and October 3, 2021: As of October 2, 2022 October 3, 2021 (in thousands) Options Vested 313 244 Unvested 1,047 1,134 RSUs 974 935 PSAs 460 433 As of October 2, 2022, total unrecognized compensation expense and remaining weighted average recognition period related to outstanding share-based awards was as follows: Unrecognized Remaining Options $ 3,781 1.1 RSUs 19,114 1.7 PSAs 784 1.4 Total unrecognized compensation expense at October 2, 2022 $ 23,679 During the thirty-nine weeks ended October 2, 2022 and October 3, 2021 , the Company received $ 4.1 million and $ 1.9 million, respectively, in cash proceeds from the exercise of options.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 02, 2022
Accounting Policies [Abstract]
Fiscal Years	The Company reports its results of operations on a 52- or 53-week fiscal calendar ending on the Sunday closest to December 31. The fiscal year ending January 1, 2023 (“fiscal year 2022”) and fiscal year 2021 are 52-week years. The Company reports its results of operations on a 13-week quarter, except for 53-week fiscal years (in which the fourth quarter has 14 weeks).
Revenue Recognition	Revenue Recognition The Company’s performance obligations are satisfied upon the transfer of goods to the customer, which occurs at the point of sale, and payment from customers is also due at the time of sale. Proceeds from the sale of gift cards are recorded as a liability at the time of sale and recognized as sales when they are redeemed by the customer and the performance obligation is satisfied by the Company. The Company’s gift cards do not expire. Based on historical redemption rates, a small and relatively stable percentage of gift cards will never be redeemed, referred to as "breakage." Estimated breakage revenue is recognized over time in proportion to actual gift card redemptions and was not material in any period presented. Balance at Gift Cards Issued During (1) Revenue Recognized from Balance at Gift card liability, net $ 12,586 $ 1,911 $ ( 5,350 ) $ 9,147 (1) net of estimated breakage The Company does not have any material contract assets or receivables from contracts with customers, any revenue recognized in the current period from performance obligations satisfied in previous periods, or any remaining performance obligations as of October 2, 2022 .
Restricted Cash	Restricted Cash Restricted cash relates to defined benefit plan forfeitures as well as healthcare, general liability and workers’ compensation restricted funds of approximately $ 2.0 million and $ 1.7 million as of October 2, 2022 and January 2, 2022 , respectively. These balances are included in prepaid expenses and other current assets in the consolidated balance sheets.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements Reference Rate Reform In March 2020 and January 2021, the FASB issued ASU no. 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting” and ASU 2021-01, “Reference Rate Reform (Topic 848): Scope,” respectively. The amendments in these updates provide optional expedients and exceptions for a limited period of time to ease the potential burden in accounting for contracts, hedging relationships, and other transactions affected by reference rate reform. In the thirty-nine weeks ended October 2, 2022 , the Company adopted certain optional expedients provided under Topic 848 that permit its hedging relationships to continue without de-designation upon changes due to reference rate reform. The adoption of this guidance resulted in no material impact to the Company’s consolidated financial statements. See Note 10, “Derivative Financial Instruments” for more information on our hedging activities. The optional expedients and accounting relief in Topic 848 remain effective through December 31, 2022.
Recently Issued Accounting Pronouncements Not Yet Adopted	Recently Issued Accounting Pronouncements Not Yet Adopted No other new accounting pronouncements issued or effective during the thirteen weeks ended October 2, 2022 had, or are expected to have, a material impact on the Company’s consolidated financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Oct. 02, 2022
Schedule of Estimated Breakage Revenue Recognized	Estimated breakage revenue is recognized over time in proportion to actual gift card redemptions and was not material in any period presented. Balance at Gift Cards Issued During (1) Revenue Recognized from Balance at Gift card liability, net $ 12,586 $ 1,911 $ ( 5,350 ) $ 9,147 (1) net of estimated breakage

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Oct. 02, 2022
Fair Value Disclosures [Abstract]
Schedule of Financial Liabilities Measured at Fair Value on Recurring Basis	The following tables present the fair value hierarchy for the Company’s financial liabilities measured at fair value on a recurring basis as of October 2, 2022 and January 2, 2022: October 2, 2022 Level 1 Level 2 Level 3 Total Long-term debt $ — $ 250,000 $ — $ 250,000 Total financial liabilities $ — $ 250,000 $ — $ 250,000 Interest rate swap asset $ — $ 687 $ — $ 687 Total assets $ — $ 687 $ — $ 687 January 2, 2022 Level 1 Level 2 Level 3 Total Long-term debt $ — $ 250,000 $ — $ 250,000 Interest rate swap liability — 5,107 — 5,107 Total financial liabilities $ — $ 255,107 $ — $ 255,107

Long-Term Debt and Finance Le_2

Long-Term Debt and Finance Lease Liabilities (Tables)	9 Months Ended
	Oct. 02, 2022
Long Term Debt And Finance Lease Liabilities [Abstract]
Summary of Long-Term Debt and Finance Lease Liabilities	A summary of long-term debt and finance lease liabilities is as follows: As of Facility Maturity Interest Rate October 2, 2022 January 2, 2022 Senior secured debt $ 700.0 million Credit Agreement March 25, 2027 Variable $ 250,000 $ — Former Credit Facility March 27, 2023 Variable — 250,000 Finance lease liabilities Various n/a 8,992 9,656 Long-term debt and finance lease liabilities $ 258,992 $ 259,656

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
	Oct. 02, 2022
Equity [Abstract]
Schedule of Common Stock Share Repurchase Programs Authorized by Board of Directors from Time to Time and Related Repurchase Activity and Available Authorized	The following table outlines the common stock share repurchase programs authorized by the Company’s board of directors and the related repurchase activity and available authorization as of October 2, 2022. Effective date Expiration date Amount Cost of Authorization March 3, 2021 March 2, 2022 $ 300,000 $ 200,200 $ — March 2, 2022 December 31, 2024 $ 600,000 $ 143,236 $ 456,764
Schedule of Share Repurchase Activity Under Share Repurchase Programs	Share repurchase activity under the Company’s repurchase programs for the periods indicated was as follows (total cost in thousands): Thirteen weeks ended Thirty-nine weeks ended October 2, 2022 October 3, 2021 October 2, 2022 October 3, 2021 Number of common shares acquired 1,558,196 2,079,420 5,437,054 5,360,037 Average price per common share acquired $ 28.25 $ 24.05 $ 28.53 $ 25.65 Total cost of common shares acquired $ 44,023 $ 50,000 $ 155,094 $ 137,484

Net Income Per Share (Tables)

Net Income Per Share (Tables)	9 Months Ended
	Oct. 02, 2022
Earnings Per Share [Abstract]
Summary of Reconciliation of Numerators and Denominators of Basic and Diluted Net Income Per Share	A reconciliation of the numerators and denominators of the basic and diluted net income per share calculations is as follows (in thousands, except per share amounts): Thirteen weeks ended Thirty-nine weeks ended October 2, 2022 October 3, 2021 October 2, 2022 October 3, 2021 Basic net income per share: Net income $ 65,740 $ 63,867 $ 216,044 $ 207,929 Weighted average shares outstanding 107,229 114,201 109,066 116,497 Basic net income per share $ 0.61 $ 0.56 $ 1.98 $ 1.78 Diluted net income per share: Net income $ 65,740 $ 63,867 $ 216,044 $ 207,929 Weighted average shares outstanding - 107,229 114,201 109,066 116,497 Dilutive effect of share-based awards: Assumed exercise of options to purchase 314 197 318 211 RSUs 266 245 371 376 PSAs 286 175 133 168 Weighted average shares and 108,095 114,818 109,888 117,252 Diluted net income per share $ 0.61 $ 0.56 $ 1.97 $ 1.77

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	9 Months Ended
	Oct. 02, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Summary of Fair Value of Derivative Instruments	The following table summarizes the fair value of the Company’s derivative instruments designated as hedging instruments: As of As of Balance Sheet Location Fair Value Balance Sheet Location Fair Value Interest rate swaps Other current assets $ 687 Other current assets $ — Interest rate swaps Accrued liabilities $ — Accrued liabilities $ 5,107
Summary of Losses of Derivative Instruments	The following table summarizes these losses classified on the consolidated statements of income: Thirteen weeks ended Thirty-nine weeks ended October 2, 2022 October 3, 2021 October 2, 2022 October 3, 2021 Consolidated Statements of Interest expense, net $ 171 $ 1,448 $ 2,705 $ 4,328

Comprehensive Income (Tables)

Comprehensive Income (Tables)	9 Months Ended
	Oct. 02, 2022
Equity [Abstract]
Schedule of Changes in Accumulated Other Comprehensive Income (Loss)	The following table presents the changes in accumulated other comprehensive income (loss) for the thirty-nine weeks ended October 3, 2021 and October 2, 2022. Cash Flow Balance at January 3, 2021 $ ( 8,474 ) Other comprehensive income (loss), net of tax Unrealized gains on cash flow hedging activities, net of income tax of $ 2,192 6,339 Reclassification of net losses on cash flow hedges to net income, net of income 1,112 ) ( 3,216 ) Total other comprehensive income (loss) 3,123 Balance at October 3, 2021 $ ( 5,351 ) Balance at January 2, 2022 $ ( 3,758 ) Other comprehensive income (loss), net of tax Unrealized gains on cash flow hedging activities, net of income tax of $ 2,167 6,266 Reclassification of net losses on cash flow hedges to net income, net of income 695 ) ( 2,010 ) Total other comprehensive income (loss) 4,256 Balance at October 2, 2022 $ 498

Segments (Tables)

Segments (Tables)	9 Months Ended
	Oct. 02, 2022
Segment Reporting [Abstract]
Summary of Disaggregation of Revenue	In accordance with ASC 606, the following table represents a disaggregation of revenue for the thirteen and thirty-nine weeks ended October 2, 2022 and October 3, 2021. Thirteen weeks ended October 2, 2022 October 3, 2021 Perishables $ 928,908 58.4 % $ 867,880 57.5 % Non-Perishables 662,118 41.6 % 641,753 42.5 % Net Sales $ 1,591,026 100.0 % $ 1,509,633 100.0 % Thirty-nine weeks ended October 2, 2022 October 3, 2021 Perishables $ 2,817,268 58.4 % $ 2,668,532 57.9 % Non-Perishables 2,010,401 41.6 % 1,938,541 42.1 % Net Sales $ 4,827,669 100.0 % $ 4,607,073 100.0 %

Share-Based Compensation (Table

Share-Based Compensation (Tables)	9 Months Ended
	Oct. 02, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Summary of Share-Based Compensation Expense in Selling, General and Administrative Expenses	The Company presents share-based compensation expense in selling, general and administrative expenses on the Company’s consolidated statements of income. The amount recognized was as follows: Thirteen weeks ended Thirty-nine weeks ended October 2, 2022 October 3, 2021 October 2, 2022 October 3, 2021 Share-based compensation expense $ 3,752 $ 3,453 $ 11,672 $ 11,304
Summary of Outstanding Share-Based Awards	The following share-based awards were outstanding as of October 2, 2022 and October 3, 2021: As of October 2, 2022 October 3, 2021 (in thousands) Options Vested 313 244 Unvested 1,047 1,134 RSUs 974 935 PSAs 460 433
Summary of Total Unrecognized Compensation Expense and Remaining Weighted Average Recognition Period Related to Outstanding Share-Based Awards	As of October 2, 2022, total unrecognized compensation expense and remaining weighted average recognition period related to outstanding share-based awards was as follows: Unrecognized Remaining Options $ 3,781 1.1 RSUs 19,114 1.7 PSAs 784 1.4 Total unrecognized compensation expense at October 2, 2022 $ 23,679
Awards Granted under the 2022 Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Summary of Share-Based Compensation Awards Granted	During the thirty-nine weeks ended October 2, 2022, the Company granted the following share-based compensation awards under the 2022 Incentive Plan: Grant Date RSUs PSAs Options June 7, 2022 58,057 — — September 7, 2022 21,598 — — Total 79,655 — — Weighted-average grant date fair value $ 27.75 $ — $ — Weighted-average exercise price — — —
Awards Granted under the 2013 Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Summary of Share-Based Compensation Awards Granted	During the thirty-nine weeks ended October 2, 2022, the Company granted the following share-based compensation awards under the 2013 Incentive Plan: Grant Date RSUs PSAs Options March 15, 2022 370,177 147,846 211,352 March 21, 2022 104,913 14,260 20,270 Total 475,090 162,106 231,622 Weighted-average grant date fair value $ 31.60 $ 31.52 $ 10.58 Weighted-average exercise price — — $ 31.52

Basis of Presentation - Additio

Basis of Presentation - Additional Information (Detail)	Oct. 02, 2022 State Store
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Operating stores | Store	379
Number of states entity operates | State	23

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Schedule of Estimated Breakage Revenue Recognized (Detail) - Gift Card Revenue [Member] $ in Thousands	9 Months Ended
	Oct. 02, 2022 USD ($)
Disaggregation Of Revenue [Line Items]
Net gift card liability beginning balance	$ 12,586
Gift cards issued during current period but not redeemed	1,911	[1]
Revenue recognized from beginning liability	(5,350)
Net gift card liability ending balance	$ 9,147
[1] net of estimated breakage

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($) $ in Millions	Oct. 02, 2022	Jan. 02, 2022
ASU no. 2021-01 [Member]
Summary Of Significant Accounting Policy [Line Items]
Change in accounting principle, ASU, adopted	true
Prepaid Expenses and Other Current Assets [Member]
Summary Of Significant Accounting Policy [Line Items]
Restricted cash related to defined benefit plan forfeitures and healthcare, general liability and workers compensation plan benefits	$ 2	$ 1.7

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Financial Liabilities Measured at Fair Value on Recurring Basis (Detail) - Recurring [Member] - USD ($) $ in Thousands	Oct. 02, 2022	Jan. 02, 2022
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Long-term debt	$ 250,000	$ 250,000
Interest rate swap liability		5,107
Total financial liabilities	250,000	255,107
Interest rate swap asset	687
Total assets	687
Level 2 [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Long-term debt	250,000	250,000
Interest rate swap liability		5,107
Total financial liabilities	250,000	$ 255,107
Interest rate swap asset	687
Total assets	$ 687

Long-Term Debt and Finance Le_3

Long-Term Debt and Finance Lease Liabilities - Summary of Long-Term Debt and Finance Lease Liabilities (Detail) - USD ($) $ in Thousands	9 Months Ended
	Oct. 02, 2022	Jan. 02, 2022
Long Term Debt And Finance Lease Liabilities [Line Items]
Long-term finance lease liabilities	$ 8,992	$ 9,656
Long-term debt and finance lease liabilities	258,992	259,656
Senior Lien [Member] | Secured Debt [Member] | $700.0 million Credit Agreement [Member]
Long Term Debt And Finance Lease Liabilities [Line Items]
Long-term debt	$ 250,000
Debt instrument maturity	Mar. 25, 2027
Debt instrument, Interest Rate	Variable
Senior Lien [Member] | Secured Debt [Member] | Former Credit Facility [Member]
Long Term Debt And Finance Lease Liabilities [Line Items]
Long-term debt		$ 250,000
Debt instrument maturity	Mar. 27, 2023
Debt instrument, Interest Rate	Variable

Long-Term Debt and Finance Le_4

Long-Term Debt and Finance Lease Liabilities - Summary of Long-Term Debt and Finance Lease Liabilities (Parenthetical) (Detail) $ in Millions	Oct. 02, 2022 USD ($)
Senior Lien [Member] | Secured Debt [Member] | $700.0 million Credit Agreement [Member]
Long Term Debt And Finance Lease Liabilities [Line Items]
Debt instrument face amount	$ 700

Long-Term Debt and Finance Le_5

Long-Term Debt and Finance Lease Liabilities - Additional Information (Detail) - USD ($)	3 Months Ended	9 Months Ended
	Oct. 02, 2022	Oct. 02, 2022	Mar. 25, 2022	Mar. 27, 2018
Credit Agreement [Member]
Long Term Debt And Finance Lease Liabilities [Line Items]
Fixed portion of outstanding debt percentage		100%
Participation fee		1%
Issuance fee		0.125%
Credit facility termination date		Mar. 25, 2027
Borrowings during the period	$ 0	$ 0
Principal payments on the Credit Facility	0	0
Borrowings under credit facilities	250,000,000	$ 250,000,000
Net leverage ratio		375%
Interest coverage ratio		3%
Secured Debt [Member] | Credit Agreement [Member] | SOFR [Member]
Long Term Debt And Finance Lease Liabilities [Line Items]
Interest rate spread on base rate		0.10%
Secured Debt [Member] | Current Credit Facility Agreement [Member] | SOFR [Member]
Long Term Debt And Finance Lease Liabilities [Line Items]
Interest rate spread on base rate		1%
Senior Lien [Member] | Secured Debt [Member] | Credit Agreement [Member]
Long Term Debt And Finance Lease Liabilities [Line Items]
Debt instrument face amount	70,000,000	$ 70,000,000
Letters of credit issued	24,800,000	$ 24,800,000
Interest rate spread on base rate		0.05%
Credit facility commitment fee percentage subject to upward or downward adjustments		0.01%
Senior Lien [Member] | Secured Debt [Member] | Credit Agreement [Member] | SOFR [Member]
Long Term Debt And Finance Lease Liabilities [Line Items]
Line of credit interest rate terms		at the Company's option, either at the Term SOFR (with a floor of 0.00%) plus a 0.10% SOFR adjustment and 1.00% per annum or base rate (with a floor of 0.00%) plus 0.00% per annum.
Senior Lien [Member] | Secured Debt [Member] | Credit Agreement [Member] | Prime Plus [Member]
Long Term Debt And Finance Lease Liabilities [Line Items]
Interest rate spread on base rate		0%
Senior Lien [Member] | Secured Debt [Member] | Credit Agreement [Member] | Minimum [Member]
Long Term Debt And Finance Lease Liabilities [Line Items]
Credit facility unused commitment fee percentage		0.10%
Senior Lien [Member] | Secured Debt [Member] | Credit Agreement [Member] | Maximum [Member]
Long Term Debt And Finance Lease Liabilities [Line Items]
Credit facility unused commitment fee percentage		0.225%
Senior Lien [Member] | Secured Debt [Member] | Credit Agreement [Member] | Swingline Loan Sub-facility [Member]
Long Term Debt And Finance Lease Liabilities [Line Items]
Debt instrument face amount	50,000,000	$ 50,000,000
Senior Lien [Member] | Secured Debt [Member] | Current Credit Facility Agreement [Member] | SOFR [Member]
Long Term Debt And Finance Lease Liabilities [Line Items]
Interest rate spread on base rate		0.10%
Senior Lien [Member] | Secured Debt [Member] | Current Credit Facility Agreement [Member] | Secured Overnight Financing Rate [Member]
Long Term Debt And Finance Lease Liabilities [Line Items]
Interest rate spread on base rate		1%
Senior Lien [Member] | Secured Debt [Member] | Former Credit Facility [Member]
Long Term Debt And Finance Lease Liabilities [Line Items]
Capitalized debt issuance costs				$ 500,000
Senior Lien [Member] | Secured Debt [Member] | $700.0 million Credit Facility [Member]
Long Term Debt And Finance Lease Liabilities [Line Items]
Debt instrument face amount	$ 700,000,000	$ 700,000,000
Senior Lien [Member] | Secured Debt [Member] | $700.0 million Credit Facility [Member] | Credit Agreement [Member]
Long Term Debt And Finance Lease Liabilities [Line Items]
Credit facility maximum borrowing capacity			$ 700,000,000
Capitalized debt issuance costs			$ 3,400,000

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Oct. 02, 2022	Oct. 03, 2021	Oct. 03, 2022	Oct. 02, 2022	Oct. 03, 2021
Income Tax Disclosure [Abstract]
Effective tax rate	25.60%	23%		25.20%	24.10%
Excess tax benefits of equity-based compensation			$ 0.2	$ 1.6

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Oct. 02, 2022	Oct. 02, 2022
Nutrition Bars Supplier [Member]
Related Party Transaction [Line Items]
Cost Of Sales Recognized from supplier	$ 1.2	$ 2.5

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail)	Apr. 13, 2010 Defendant
Superior Court of State of California and County of Los Angeles [Member]
Other Commitments [Line Items]
Number of defendants	80

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Detail) - USD ($) shares in Millions	Nov. 04, 2022	Oct. 02, 2022	Mar. 02, 2022
Equity Class Of Treasury Stock [Line Items]
Common stock repurchased during the period, value	$ 17,800,000
Subsequent Event [Member]
Equity Class Of Treasury Stock [Line Items]
Common stock repurchased during the period, shares	0.6
March 3, 2021 Share Repurchase Program [Member]
Equity Class Of Treasury Stock [Line Items]
Shares authorized to be repurchased		$ 300,000,000	$ 300,000,000
Authorization available		0	99,800,000
March 2, 2022 [Member]
Equity Class Of Treasury Stock [Line Items]
Shares authorized to be repurchased		600,000,000	$ 600,000,000
Authorization available		$ 456,764,000

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of Common Stock Share Repurchase Programs Authorized by Board of Directors from Time to Time and Related Repurchase Activity and Available Authorized (Detail) - USD ($)	9 Months Ended
	Oct. 02, 2022	Oct. 03, 2021	Mar. 02, 2022
Equity Class Of Treasury Stock [Line Items]
Cost of repurchases	$ 155,094,000	$ 137,484,000
March 3, 2021 [Member]
Equity Class Of Treasury Stock [Line Items]
Effective date	Mar. 03, 2021
Expiration date	Mar. 02, 2022
Amount authorized	$ 300,000,000		$ 300,000,000
Cost of repurchases	200,200,000
Authorization available	$ 0		99,800,000
March 2, 2022 [Member]
Equity Class Of Treasury Stock [Line Items]
Effective date	Mar. 02, 2022
Expiration date	Dec. 31, 2024
Amount authorized	$ 600,000,000		$ 600,000,000
Cost of repurchases	143,236,000
Authorization available	$ 456,764,000

Stockholders' Equity - Schedu_2

Stockholders' Equity - Schedule of Share Repurchase Activity under Share Repurchase Programs (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2022	Oct. 03, 2021	Oct. 02, 2022	Oct. 03, 2021
Equity [Abstract]
Number of common shares acquired	1,558,196	2,079,420	5,437,054	5,360,037
Average price per common share acquired	$ 28.25	$ 24.05	$ 28.53	$ 25.65
Total cost of common shares acquired	$ 44,023	$ 50,000	$ 155,094	$ 137,484

Net Income Per Share - Summary

Net Income Per Share - Summary of Reconciliation of Numerators and Denominators of Basic and Diluted Net Income Per Share (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2022	Oct. 03, 2021	Oct. 02, 2022	Oct. 03, 2021
Basic net income per share:
Basic net income per share	$ 0.61	$ 0.56	$ 1.98	$ 1.78
Diluted net income per share:
Net income	$ 65,740	$ 63,867	$ 216,044	$ 207,929
Weighted average shares outstanding - basic	107,229,000	114,201,000	109,066,000	116,497,000
Dilutive effect of share-based awards:
Assumed exercise of options to purchase shares	314,000	197,000	318,000	211,000
Weighted average shares and equivalent shares outstanding	108,095,000	114,818,000	109,888,000	117,252,000
Diluted net income per share	$ 0.61	$ 0.56	$ 1.97	$ 1.77
RSUs [Member]
Dilutive effect of share-based awards:
Dilutive effect	266,000	245,000	371,000	376,000
PSAs [Member]
Dilutive effect of share-based awards:
Dilutive effect	286,000	175,000	133,000	168,000

Net Income Per Share - Addition

Net Income Per Share - Additional Information (Detail) - shares shares in Millions	3 Months Ended		9 Months Ended
	Oct. 02, 2022	Oct. 03, 2021	Oct. 02, 2022	Oct. 03, 2021
Stock option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities	0.3	0.5	0.5	0.5
RSUs [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities			0.1
PSAs [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities	0.3	0.3	0.3	0.3

Derivative Financial Instrume_3

Derivative Financial Instruments - Additional Information (Detail) $ in Millions	9 Months Ended
	Oct. 02, 2022 USD ($) Hedge Swap	Jan. 02, 2022 USD ($)
Derivative [Line Items]
Derivative, cash flow swaps length period	1 year
Cash flow swaps mature annually, ending year	2022
Cash Flow Hedges [Member]
Derivative [Line Items]
Interest rate swaps hedge ineffectiveness	0%
Swaps [Member]
Derivative [Line Items]
Derivative, notional amount of outstanding swaps | $	$ 250	$ 250
Forward Contract [Member]
Derivative [Line Items]
Derivative, number of cash flow hedges | Hedge	5
Number of outstanding swaps | Swap	1

Derivative Financial Instrume_4

Derivative Financial Instruments - Summary of Fair Value of Derivative Instruments (Detail) - Designated as Hedging Instrument [Member] - Swaps [Member] - USD ($) $ in Thousands	Oct. 02, 2022	Jan. 02, 2022
Derivatives Fair Value [Line Items]
Liability Derivatives, Fair Value		$ 5,107
Asset Derivatives, Fair Value	$ 687

Derivative Financial Instrume_5

Derivative Financial Instruments - Summary of Losses of Derivative Instruments (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2022	Oct. 03, 2021	Oct. 02, 2022	Oct. 03, 2021
Derivative Instruments Gain Loss [Line Items]
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Interest Income (Expense), Net	Interest Income (Expense), Net	Interest Income (Expense), Net	Interest Income (Expense), Net
Interest expense, net	$ 171	$ 1,448	$ 2,705	$ 4,328

Comprehensive Income - Changes

Comprehensive Income - Changes In Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2022	Oct. 03, 2021	Oct. 02, 2022	Oct. 03, 2021
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning Balance	$ 1,013,690	$ 949,123	$ 959,876	$ 881,293
Other comprehensive income (loss), net of tax
Unrealized gains on cash flow hedging activities, net of income tax	432	2,044	6,266	6,339
Reclassification of net gains (losses) on cash flow hedges to net income, net of income tax	(127)	(1,076)	(2,010)	(3,216)
Total other comprehensive income (loss)	305	968	4,256	3,123
Ending Balance	1,040,828	968,083	1,040,828	968,083
Cash Flow Hedges [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning Balance			(3,758)	(8,474)
Other comprehensive income (loss), net of tax
Unrealized gains on cash flow hedging activities, net of income tax			6,266	6,339
Reclassification of net gains (losses) on cash flow hedges to net income, net of income tax			(2,010)	(3,216)
Total other comprehensive income (loss)			4,256	3,123
Ending Balance	$ 498	$ (5,351)	$ 498	$ (5,351)

Comprehensive Income - Change_2

Comprehensive Income - Changes In Accumulated Other Comprehensive Income (Loss) (Parenthetical) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2022	Oct. 03, 2021	Oct. 02, 2022	Oct. 03, 2021
Accumulated Other Comprehensive Income Loss [Line Items]
Income tax expenses (Benefit) on cash flow hedging activities	$ 149	$ 707	$ 2,167	$ 2,192
Income tax expenses (Benefit) for reclassification of net gains (losses) on cash flow hedges	$ (44)	$ (372)	(695)	(1,112)
Cash Flow Hedges [Member]
Accumulated Other Comprehensive Income Loss [Line Items]
Income tax expenses (Benefit) on cash flow hedging activities			2,167	2,192
Income tax expenses (Benefit) for reclassification of net gains (losses) on cash flow hedges			$ (695)	$ (1,112)

Segments - Additional Informati

Segments - Additional Information (Detail)	9 Months Ended
	Oct. 02, 2022 Segment
Segment Reporting [Abstract]
Number of reportable segment	1
Number of operating segment	1

Segments - Summary of Disaggreg

Segments - Summary of Disaggregation of Revenue (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2022	Oct. 03, 2021	Oct. 02, 2022	Oct. 03, 2021
Disaggregation Of Revenue [Line Items]
Net Sales, amount	$ 1,591,026	$ 1,509,633	$ 4,827,669	$ 4,607,073
Sales Revenue, Goods, Net [Member] | Product Concentration Risk [Member]
Disaggregation Of Revenue [Line Items]
Net Sales, percentage	100%	100%	100%	100%
Perishables [Member]
Disaggregation Of Revenue [Line Items]
Net Sales, amount	$ 928,908	$ 867,880	$ 2,817,268	$ 2,668,532
Perishables [Member] | Sales Revenue, Goods, Net [Member] | Product Concentration Risk [Member]
Disaggregation Of Revenue [Line Items]
Net Sales, percentage	58.40%	57.50%	58.40%	57.90%
Non-Perishables [Member]
Disaggregation Of Revenue [Line Items]
Net Sales, amount	$ 662,118	$ 641,753	$ 2,010,401	$ 1,938,541
Non-Perishables [Member] | Sales Revenue, Goods, Net [Member] | Product Concentration Risk [Member]
Disaggregation Of Revenue [Line Items]
Net Sales, percentage	41.60%	42.50%	41.60%	42.10%

Share-Based Compensation - Summ

Share-Based Compensation - Summary of Stock-Based Compensation Awards Granted (Detail)	9 Months Ended
	Oct. 02, 2022 $ / shares shares
2013 Incentive Plan [Member] | RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock	475,090
Weighted-average grant date fair value | $ / shares	$ 31.60
Weighted-average exercise price | $ / shares	$ 0
2013 Incentive Plan [Member] | PSAs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock	162,106
Weighted-average grant date fair value | $ / shares	$ 31.52
Weighted-average exercise price | $ / shares	$ 0
2013 Incentive Plan [Member] | Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock	231,622
Weighted-average grant date fair value | $ / shares	$ 10.58
Weighted-average exercise price | $ / shares	$ 31.52
2013 Incentive Plan [Member] | March 15, 2022 [Member] | RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock	370,177
2013 Incentive Plan [Member] | March 15, 2022 [Member] | PSAs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock	147,846
2013 Incentive Plan [Member] | March 15, 2022 [Member] | Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock	211,352
2013 Incentive Plan [Member] | March 21, 2022 [Member] | RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock	104,913
2013 Incentive Plan [Member] | March 21, 2022 [Member] | PSAs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock	14,260
2013 Incentive Plan [Member] | March 21, 2022 [Member] | Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock	20,270
Awards Granted under the 2022 Incentive Plan [Member] | RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock	79,655
Weighted-average grant date fair value | $ / shares	$ 27.75
Weighted-average exercise price | $ / shares	$ 0
Awards Granted under the 2022 Incentive Plan [Member] | PSAs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock	0
Weighted-average grant date fair value | $ / shares	$ 0
Weighted-average exercise price | $ / shares	$ 0
Awards Granted under the 2022 Incentive Plan [Member] | Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock	0
Weighted-average grant date fair value | $ / shares	$ 0
Weighted-average exercise price | $ / shares	$ 0
Awards Granted under the 2022 Incentive Plan [Member] | June 7, 2022 [Member] | RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock	58,057
Awards Granted under the 2022 Incentive Plan [Member] | June 7, 2022 [Member] | PSAs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock	0
Awards Granted under the 2022 Incentive Plan [Member] | June 7, 2022 [Member] | Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock	0
Awards Granted under the 2022 Incentive Plan [Member] | September 7, 2022 [Member] | RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock	21,598
Awards Granted under the 2022 Incentive Plan [Member] | September 7, 2022 [Member] | PSAs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock	0
Awards Granted under the 2022 Incentive Plan [Member] | September 7, 2022 [Member] | Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of common stock	0

Share-Based Compensation - Addi

Share-Based Compensation - Additional Information (Detail) - USD ($) $ in Thousands	1 Months Ended	9 Months Ended		12 Months Ended
	Mar. 31, 2018	Oct. 02, 2022	Oct. 03, 2021	Jan. 03, 2021	Dec. 29, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Proceeds from exercise of stock options		$ 4,074	$ 1,918
Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Proceeds from exercise of stock options		$ 4,100	$ 1,900
RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares, outstanding		974,000	935,000
RSUs [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period		2 years
RSUs [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period		3 years
PSAs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares, outstanding		460,000	433,000
PSAs [Member] | March 2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance stock awards description		The criteria was based on a range of performance targets in which grantees may earn 0% to 200% of the base number of awards granted.
Number of shares, outstanding		0
PSAs [Member] | 2019 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance stock awards description		The criteria is based on a range of performance targets in which grantees may earn 0% to 200% of the base number of awards granted.
Awards vested		208,172
Number of shares, outstanding		0
PSAs [Member] | 2020 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance stock awards description		The criteria is based on a range of performance targets in which grantees may earn 0% to 200% of the base number of awards granted.
PSAs [Member] | 2021 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance stock awards description		The criteria is based on a range of performance targets in which grantees may earn 0% to 200% of the base number of awards granted.
PSAs [Member] | 2022 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance stock awards description		The criteria is based on a range of performance targets in which grantees may earn 0% to 200% of the base number of awards granted.
PSAs [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance stock awards payout percentage of shares granted	0%	0%		0%	0%
PSAs [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance stock awards payout percentage of shares granted	200%	200%		200%	200%
Third Anniversary [Member] | Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period		3 years
Awards Granted under the 2022 Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized for issuance under plan		6,600,000
Stock awards outstanding		79,655
Remaining shares available for issuance		6,621,800

Share-Based Compensation - Su_2

Share-Based Compensation - Summary of Share-Based Compensation Expense in Selling, General and Administrative Expenses (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 02, 2022	Oct. 03, 2021	Oct. 02, 2022	Oct. 03, 2021
Share-Based Payment Arrangement [Abstract]
Share-based compensation expense	$ 3,752	$ 3,453	$ 11,672	$ 11,304

Share-Based Compensation - Su_3

Share-Based Compensation - Summary of Outstanding Share-Based Awards (Detail) - shares shares in Thousands	Oct. 02, 2022	Oct. 03, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested options, outstanding	313	244
Unvested options, outstanding	1,047	1,134
RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based awards other than options, outstanding	974	935
PSAs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity-based awards other than options, outstanding	460	433

Share-Based Compensation - Su_4

Share-Based Compensation - Summary of Total Unrecognized Compensation Expense and Remaining Weighted Average Recognition Period Related to Outstanding Share-Based Awards (Detail) $ in Thousands	9 Months Ended
	Oct. 02, 2022 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation expense at July 3, 2022	$ 23,679
Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense related to outstanding options	$ 3,781
Remaining weighted average recognition period	1 year 1 month 6 days
RSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense related to outstanding equity-based awards other than options	$ 19,114
Remaining weighted average recognition period	1 year 8 months 12 days
PSAs [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense related to outstanding equity-based awards other than options	$ 784
Remaining weighted average recognition period	1 year 4 months 24 days